Klinische Studie

A multicenter randomized clinical trial comparing transanal total mesorectal excision (TME) versus laparoscopic TME for mid and low rectal cancer.(Color III Study)735 in the TaTME arm and 369 in the laparoscopic TME arm to demonstrate a non-inferior effect on local recurrence of 4% after 3 years between the control group an the TaTME group.
Krankheitsentität(en) Darm (Dickdarm, Mastdarm)
Wesentliche Einschlusskriterienmid or low rectal cancer, distance 0-10 cm from anal verge (MRI defined) Histological biopsy showing adenocarcinoma Stage I-III (MRI and CT abdomen), curative intent (including downstaged after neoadjuvant therapy) Intention for primary anastomosis
Wesentliche AusschlusskriterienT4 tumour and T3 with MRF involvement on MRI (after neoadjuvant therapy) Ingrowth in anal sphincter complex or m. levator requiring abdominoperineal resection Previous rectal resection (excl local excision), prostatectomy
Ansprechpartner & KontaktCaritas-Krankenhaus St. Josef RegensburgChirurgie - St. JosefStudienzentrale0941 7823811chir-studienzentrum(at)csj.de